Archives
-
Computational Hapten Design for Dual Toxin Detection
2026-10-07
The reference study combines molecular-similarity analysis, quantum chemical calculations, and rational hapten design to improve antibody recognition of major amatoxins and phallotoxins. Its dual-target fluorescent immunochromatographic assay reported low detection limits in mushroom matrices, supporting rapid screening while leaving questions about broader validation and transferability.
-
Thermal Shift Assays for Bacterial Sensor Ligands
2026-10-07
Monteagudo-Cascales and colleagues review how thermal shift assays can reveal ligands for bacterial receptors, solute-binding proteins, and transcriptional regulators whose signals are difficult to predict from sequence alone. The paper’s main contribution is a reliability-focused interpretation of thermal shifts, emphasizing soluble ligand-binding domains, pH-dependent assay behavior, and confirmation with direct binding methods such as isothermal titration calorimetry.
-
Annexin V in NSCLC Cell-Death Interpretation
2026-10-06
Annexin V is a phosphatidylserine binding protein that can connect membrane-state measurements with modern cancer research. This article examines how Annexin V-based apoptosis assay readouts could complement the CIP2A–PKM2 metabolic findings in non-small cell lung cancer while separating reported evidence from testable interpretation.
-
(S,S)-Nanaomycin A in NEPC Research
2026-10-06
Explore how (S,S)-Nanaomycin A is used to investigate DNMT3B-driven lineage plasticity in neuroendocrine prostate cancer. This article explains the study’s mechanistic insight, evidence boundaries, and implications for epigenetic research.
-
Mitochondrial Calcium Signaling and Ferroptosis
2026-10-05
A 2023 Research Square preprint links mitochondrial calcium uptake through MCU to GPX4 acetylation, sustained antioxidant activity, and suppression of ferroptotic cell death. Its findings connect mitochondrial metabolism with ferroptosis control while also highlighting important limits related to preprint status, model specificity, and translation.
-
HotStart™ 2X Green qPCR Master Mix: Evidence Guide
2026-10-05
This evidence-focused guide examines how HotStart 2X Green qPCR Master Mix can support interpretation of inflammatory and cancer-related gene-expression data. It connects SYBR Green assay chemistry with the findings, mechanistic claims, and limitations of a 2025 oridonin study in esophageal cancer.
-
A23187, Free Acid: From Calcium Flux to Translation
2026-10-04
A mechanistic and translational framework for interpreting A23187, free acid as a calcium ionophore. This article connects intracellular Ca2+ perturbation with apoptosis, phosphoinositide signaling, ROS generation, and Zn2+-associated cell death while applying Schwartz’s distinction between relative and fractional viability to improve evidence quality in cancer research.
-
LDN-193189: Reliable ALK Inhibitor Assays
2026-10-02
Learn how LDN-193189 supports reproducible BMP pathway, viability, proliferation, and epithelial barrier studies through defined potency, handling, and control strategies. This scenario-based guide explains how SKU A8324 can be evaluated for assay compatibility, optimization, interpretation, and practical laboratory reliability.
-
Mitochondrial Calcium Signaling in Ferroptosis
2026-10-01
The reference study links mitochondrial calcium uptake through MCU to sustained GPX4 activity by promoting acetyl-CoA-dependent acetylation at GPX4 K90. Its genetic, structural, and in vivo evidence suggests that mitochondrial calcium signaling can suppress ferroptosis and influence tumor growth, while also identifying important limits for translating the mechanism across models.
-
Imipramine: From Autophagy Signal to Assay Strategy
2026-10-01
Imipramine is a tricyclic antidepressant with research relevance across autophagy, apoptosis, neuroscience, and immunology. This guide translates ceramide–autophagy findings from fish nodavirus research into a rigorous framework for designing and interpreting Imipramine-based cellular assays without overstating cross-domain evidence.
-
Pentoxifylline and Preterm Monocyte Hyperinflammation
2026-09-30
Schüller and colleagues used an age-stratified whole-blood model to show that pentoxifylline suppresses LPS-driven monocyte activation in preterm infants, with particularly strong effects on TLR4 expression, inflammatory cytokines, and selected surface markers. The study provides a mechanistic framework for interpreting pentoxifylline as an immunomodulator while emphasizing that neonatal responses differ from those of adults.
-
FDXR Disease, NRF2 Disruption, and Ferroptosis
2026-09-30
Campbell and colleagues identify ferroptosis as a pathogenic mechanism in FDXR-related mitochondrial disease, linking abnormal iron handling to membrane lipid peroxidation and impaired NRF2–SLC7A11 antioxidant signaling. Their mouse-model data also show that NRF2 activation with omaveloxolone can mitigate disease-associated pathology, providing a mechanistic basis for future therapies targeting redox regulation.
-
Pam3CSK4 TFA: TLR1/2 Assay Workflows
2026-09-29
Pam3CSK4 TFA provides a defined TLR1/2 agonist stimulus for separating receptor-specific innate signaling from the complexity of whole-bacterium exposure. This guide translates maternal–neonatal GBS findings into practical cytokine-profiling workflows, controls, and troubleshooting decisions.
-
Aneugen Molecular Mechanism Assay: Key Findings
2026-09-29
The reference study introduces a tiered flow-cytometric strategy for distinguishing tubulin destabilization, tubulin stabilization, and mitotic kinase inhibition as causes of chemical-induced aneugenicity. Its combination of 488 Taxol response, phospho-histone H3, Ki-67, and machine learning classified most tested compounds according to their expected molecular targets.
-
Pentoxifylline Modulates LPS Responses in Preterm Monocytes
2026-09-28
Schüller and colleagues examined how pentoxifylline reshapes LPS-induced monocyte activation in preterm and term infants compared with adults. The study links dose-dependent suppression of inflammatory markers and phagocytosis to reduced TLR4 expression and signaling, while revealing age-dependent differences in CD14, CD11b, and IL-10 responses.